Sermorelin, also known as GHRH 1-29, is a synthetic 29-amino-acid analogue of endogenous growth hormone-releasing hormone studied for its relevance to GHRH receptor pathway research, pituitary-axis signalling models, somatotroph receptor research, endocrine signalling mechanisms, and downstream receptor-signalling pathways.